228 related articles for article (PubMed ID: 31329941)
1. Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.
Koch MJ; Agarwalla PK; Royce TJ; Shih HA; Oh K; Niemierko A; Mauceri TC; Curry WT; Barker FG; Loeffler JS
Neurosurgery; 2019 Nov; 85(5):E910-E916. PubMed ID: 31329941
[TBL] [Abstract][Full Text] [Related]
2. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
[TBL] [Abstract][Full Text] [Related]
4. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
J Neurosurg; 2018 Dec; 131(6):1819-1828. PubMed ID: 30579269
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.
Wernicke AG; Yondorf MZ; Peng L; Trichter S; Nedialkova L; Sabbas A; Kulidzhanov F; Parashar B; Nori D; Clifford Chao KS; Christos P; Kovanlikaya I; Pannullo S; Boockvar JA; Stieg PE; Schwartz TH
J Neurosurg; 2014 Aug; 121(2):338-48. PubMed ID: 24785322
[TBL] [Abstract][Full Text] [Related]
6. Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.
Abou Al-Shaar H; Almefty KK; Abolfotoh M; Arvold ND; Devlin PM; Reardon DA; Loeffler JS; Al-Mefty O
J Neurooncol; 2015 Sep; 124(3):515-22. PubMed ID: 26253325
[TBL] [Abstract][Full Text] [Related]
7. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
Mooney MA; Bi WL; Cantalino JM; Wu KC; Harris TC; Possatti LL; Juvekar P; Hsu L; Dunn IF; Al-Mefty O; Devlin PM
J Neurooncol; 2020 Jan; 146(1):111-120. PubMed ID: 31745706
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution.
Pisćević I; Villa A; Milićević M; Ilić R; Nikitović M; Cavallo LM; Grujičić D
World Neurosurg; 2015 Jun; 83(6):987-95. PubMed ID: 25769488
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
Wu A; Jin MC; Meola A; Wong HN; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
[TBL] [Abstract][Full Text] [Related]
10. Atypical Meningiomas: Recurrence, Reoperation, and Radiotherapy.
Klinger DR; Flores BC; Lewis JJ; Hatanpaa K; Choe K; Mickey B; Barnett S
World Neurosurg; 2015 Sep; 84(3):839-45. PubMed ID: 25916182
[TBL] [Abstract][Full Text] [Related]
11. CyberKnife Stereotactic Radiosurgery for Atypical and Malignant Meningiomas.
Zhang M; Ho AL; D'Astous M; Pendharkar AV; Choi CY; Thompson PA; Tayag AT; Soltys SG; Gibbs IC; Chang SD
World Neurosurg; 2016 Jul; 91():574-581.e1. PubMed ID: 27108030
[TBL] [Abstract][Full Text] [Related]
12. Sphenoid Wing Meningiomas: Surgical Outcomes in a Series of 141 Cases and Proposal of a Scoring System Predicting Extent of Resection.
Güdük M; Özduman K; Pamir MN
World Neurosurg; 2019 May; 125():e48-e59. PubMed ID: 30639480
[TBL] [Abstract][Full Text] [Related]
13. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
14. Atypical and malignant meningiomas: an outcome report of seventeen cases.
Coke CC; Corn BW; Werner-Wasik M; Xie Y; Curran WJ
J Neurooncol; 1998 Aug; 39(1):65-70. PubMed ID: 9760071
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
16. Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.
Wernicke AG; Smith AW; Taube S; Yondorf MZ; Parashar B; Trichter S; Nedialkova L; Sabbas A; Christos P; Ramakrishna R; Pannullo SC; Stieg PE; Schwartz TH
J Neurosurg; 2017 Apr; 126(4):1212-1219. PubMed ID: 27257835
[TBL] [Abstract][Full Text] [Related]
17. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy for atypical meningiomas.
Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
[TBL] [Abstract][Full Text] [Related]
20. Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors.
Chen WC; Lafreniere M; Phuong C; Liu SJ; Baal JD; Lometti M; Morin O; Ziemer B; Vasudevan HN; Lucas CG; Hervey-Jumper SL; Theodosopoulos PV; Magill ST; Fogh S; Nakamura JL; Boreta L; Sneed PK; McDermott MW; Raleigh DR; Braunstein SE
J Neurosurg; 2022 Oct; 137(4):924-930. PubMed ID: 35061986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
